Thermo Fisher Scientific (TMO) PT Raised to $650 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $706.16 --0%
Rating Summary:
35 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
35 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
UBS analyst John Sourbeer raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $650.00 (from $640.00) while maintaining a Buy rating.
You May Also Be Interested In
- Acadia Pharmaceuticals (ACAD) PT Raised to $38 at RBC Capital
- Hut 8 Mining Corp. (HUT) PT Lowered to $127 at Cantor Fitzgerald
- Emerson (EMR) PT Raised to $196 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
